INSTRUCT for Repair of Knee Cartilage Defects

NCT ID: NCT01041885

Last Updated: 2015-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate whether the INSTRUCT therapy is safe and effective in the treatment of cartilage defects of the knee.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, open-label, single-arm pilot study designed to investigate the safety and efficacy of the INSTRUCT therapy in the treatment of knee cartilage defects.

All patients who meet eligibility criteria and who consent to participate will undergo the implantation of a biodegradable scaffold seeded with autologous primary chondrocytes and bone marrow cells via arthrotomy.

Patients will be followed-up for 2 years at regular intervals. Evaluations will include adverse events collection, patient reported outcomes (mostly pain and function), arthroscopic and histologic evaluations and MRIs (including dGEMRIC).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Articular Cartilage Lesion of the Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

INSTRUCT

INSTRUCT scaffold implantation

Group Type EXPERIMENTAL

INSTRUCT

Intervention Type DEVICE

INSTRUCT PolyActive scaffold implantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

INSTRUCT

INSTRUCT PolyActive scaffold implantation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a symptomatic articular cartilage defect in the knee

Exclusion Criteria

* Surgery on the study knee joint within 6 months
* Patients with significant malalignment (more than 5°)
* Patients with ligamentous instability of the knee
* Majority of the meniscus absent
* Severe osteoarthritis
* Intake of medications or treatments having an effect on bone or cartilage formation
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CellCoTec B.V.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joël Guidoux

Role: STUDY_DIRECTOR

CellCoTec B.V.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Gent

Ghent, , Belgium

Site Status

University Hospital nber 2 Dr. Jana Biziela

Bydgoszcz, , Poland

Site Status

NZOZ "Szpital AVIMED" sp. z o.o.

Katowice, , Poland

Site Status

NZOZ Endomedical

Poznan, , Poland

Site Status

Centrum Medycyny Sportowej (Sports Medicine Center CMS)

Warsaw, , Poland

Site Status

Royal Orthopaedic Hospital

Birmingham, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Poland United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Slynarski K, de Jong WC, Snow M, Hendriks JAA, Wilson CE, Verdonk P. Single-Stage Autologous Chondrocyte-Based Treatment for the Repair of Knee Cartilage Lesions: Two-Year Follow-up of a Prospective Single-Arm Multicenter Study. Am J Sports Med. 2020 May;48(6):1327-1337. doi: 10.1177/0363546520912444. Epub 2020 Apr 8.

Reference Type DERIVED
PMID: 32267734 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

309-019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NeoCart Phase 2 Clinical Trial
NCT00548119 COMPLETED PHASE2